MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Alignment of objective markers of speech with listener based judgements and disease severity in Friedreich ataxia

    A. Vogel, A. Tsanas, H. Reece, L. Corben, G. Tai, M. Delatycki (Melbourne, Australia)

    Objective: To identify a subset of acoustic markers of speech that objectively describe listener perceptions, disease severity and speech related quality of life in Friedreich…
  • 2019 International Congress

    Post-pump chorea and progressive supranuclear palsy like syndrome following major cardiac surgery: A case series

    GW. Kim, KW. Park, NR. Choi, HS. Ryu, HJ. Kim, CS. Lee, SJ. Chung (Daegu, Republic of Korea)

    Objective: We report three patients who developed movement disorders after major cardiac surgery and suggest a common underlying mechanism. Background: Choreiform movement disorder occurs in…
  • 2019 International Congress

    The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in 270 Thai patients

    T. Sangpeamsook, Y. Pitakpatapee, A. Suengtaworn, J. Srikajon, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics and treatment outcomes after injecting Botulinum neurotoxin type A (BoNT-A) between non-troublesome and troublesome hemifacial spasm (HFS) in Thais.…
  • 2019 International Congress

    Development of Mucoadhesive Sustained Release Floating Tablets of Silymarin using Natural Polymer for Improved Anti-Parkinson Efficacy

    D. Gugulothu, R. Nagapuri, DK. Khatri (Pune, India)

    Objective: The objective of the present investigation was to develop Mucoadhesive sustained release floating tablets of Silymarin using natural polymers (Coccinia grandis and Rumex vasicarious)…
  • 2019 International Congress

    Effect of dopamine D2-receptor antagonist and basal ganglia neuromodulation on neuronal activity in the cerebral motor area and cerebellar dentate nucleus

    K. Schwabe, A. Abdulbaki, S. Helgers, J. Krauss, M. Alam (Hannover, Germany)

    Objective: The effect of the D2-antagonist haloperidol on single unit activity (SU) and local field potentials (LFPs) of the cerebellar dentate nucleus and motor cortex…
  • 2019 International Congress

    Isolated delusion in idiopathic Parkinson’s disease: particularities in a subgroup of patients

    A. Gonçalves, A. Delgado, J. Velosa, R. Simões, J. Vale (Loures, Portugal)

    Objective: Characterize the subgroup of Parkinson’s Disease (PD) patients with isolated delusions. Background: Psychotic features in patients with PD, especially delusions, usually are thought to…
  • 2019 International Congress

    Functional stiff person like disorders: clinical features and red flags

    B. Balint, A. Jha, M. Edwards, HM. Meinck, K. Bhatia (London, United Kingdom)

    Objective: To delineate the characteristics and distinguishing features of functional stiff person-like disorders (fSPLD). Background: Stiff person spectrum disorders (SPSD) are a group of rare…
  • 2019 International Congress

    Preoperative quantitative evaluation of psychological determinants in abnormal head postures

    E. Sanrey, C. Labate, L. Cif, V. Gonzalez, E. Borgeais, E. Chan Seng, P. Coubes (Montpellier, France)

    Objective: Improving the diagnostic capability by discriminating the psychogenic part of the disorder using a dedicated “home-made” questionnaire completed with the Minnesota Multiphasic Personality Inventory (MMPI).…
  • 2019 International Congress

    Identification of aberrant circulating miRNAs in Parkinson’s disease plasma samples

    L. Chen, J. Yang (Tianjin, China)

    Objective: To detect the aberrant expression of circulating miRNAs and explore thepotential early diagnostic biomarkers in patients with Parkinson’s disease (PD). Background: In the past…
  • 2019 International Congress

    GBA p.Glu326Lys substitution increases the risk to develop Parkinson’s disease; is it enough to affect disease phenotype?

    O. Goldstein, M. Gana- Weisz, D. Cohen-Avinoam, A. Bar-Shira, A. Thaler, T. Shiner, A. Mirelman, N. Giladi, A. Orr-Urtreger (Tel Aviv, Israel)

    Objective: To evaluate the frequency of GBA p.Glu326Lys (E326K) carriers in a large cohort of Parkinson's disease patients of Ashkenazi Jewish origin (AJPD) and to…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley